Login / Signup

Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves et al.

Leonieke J J van MensMarleen G H van de SandeArno W R van KuijkDominique BaetenLaura C Coates
Published in: Annals of the rheumatic diseases (2019)
Keyphrases
  • prostate cancer
  • radical prostatectomy